These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3728534

  • 1. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
    Phillips I, King A, Shannon K.
    Am J Med; 1986 Jun 30; 80(6B):48-55. PubMed ID: 3728534
    [Abstract] [Full Text] [Related]

  • 2. Aminoglycoside resistance among blood culture isolates.
    Huovinen P, Grönroos P, Herva E, Katila ML, Klossner ML, Renkonen OV, Toivanen P.
    J Clin Microbiol; 1984 Jul 30; 20(1):65-9. PubMed ID: 6378968
    [Abstract] [Full Text] [Related]

  • 3. Review of epidemic aminoglycoside resistance worldwide.
    Mayer KH.
    Am J Med; 1986 Jun 30; 80(6B):56-64. PubMed ID: 3089005
    [Abstract] [Full Text] [Related]

  • 4. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH.
    Infection; 1976 Jun 30; 4(2):35-41. PubMed ID: 789246
    [Abstract] [Full Text] [Related]

  • 5. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J, Ponce de Leon S, Calva JJ, Huazano F, Ontiveros C, Ojeda F, Bobadilla M.
    Am J Med; 1986 Jun 30; 80(6B):71-5. PubMed ID: 3089006
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H.
    J Infect Dis; 1976 Nov 30; 134 SUPPL():S271-4. PubMed ID: 825585
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C, Kauffman CA.
    Infection; 1978 Nov 30; 6(3):111-5. PubMed ID: 98451
    [Abstract] [Full Text] [Related]

  • 8. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA, Nathan C, Cohen S.
    Antimicrob Agents Chemother; 1976 Jul 30; 10(1):139-45. PubMed ID: 825021
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E, Schoutens E, Vanderlinden MP.
    Chemotherapy; 1975 Jul 30; 21(1):45-51. PubMed ID: 807457
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD, Draus LL, Pasieczinik KA.
    Antimicrob Agents Chemother; 1976 Oct 30; 10(4):677-81. PubMed ID: 825036
    [Abstract] [Full Text] [Related]

  • 11. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M.
    Med Klin; 1978 Jun 16; 73(24):914-7. PubMed ID: 661734
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov 16; 134 SUPPL():S394-90. PubMed ID: 825591
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW, Boelaert J, Glibert B, Gordts B, Verbruggen AM.
    Am J Med; 1986 Jun 30; 80(6B):76-81. PubMed ID: 3089007
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH, Nevárez M, Gutiérrez-Núñez JJ, Reyes Y.
    Bol Asoc Med P R; 1983 Jul 30; 75(7):305-7. PubMed ID: 6442865
    [No Abstract] [Full Text] [Related]

  • 16. In vitro study of netilmicin compared with other aminoglycosides.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1976 Sep 30; 10(3):526-34. PubMed ID: 10829
    [Abstract] [Full Text] [Related]

  • 17. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ, Towner K, Greenwood D.
    J Med Microbiol; 1981 May 30; 14(2):171-83. PubMed ID: 7014903
    [Abstract] [Full Text] [Related]

  • 18. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used.
    Busch-Sørensen C, Sönmezoglu M, Frimodt-Møller N, Højbjerg T, Miller GH, Espersen F.
    APMIS; 1996 Oct 30; 104(10):763-8. PubMed ID: 8980628
    [Abstract] [Full Text] [Related]

  • 19. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A, Montini G, Ramacciotti PG.
    Chemioterapia; 1985 Dec 30; 4(6):439-44. PubMed ID: 3830413
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of gentamicin resistance in nosocomial infections.
    John JF, Rubens CE, Farrar WE.
    Am J Med Sci; 1980 Dec 30; 279(1):25-30. PubMed ID: 6768292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.